ICCM
IceCure Medical·NASDAQ
--
--(--)
--
--(--)
7.66 / 10
Outperform
Sentiment is strong (7.66/10) with a 100% Strong‑Buy consensus and good fund‑flow score (7.26). Inflows are positive across most sizes, though the stock price slipped slightly. Analyst coverage is limited but optimistic.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Yi ChenStrong Buy
Date2025-10-07
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for ICCM?
- ICCM holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.66/10 (Outperform).
